Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-03-22 Purchase | 2024-03-25 7:10 pm | Design Therapeutics Inc. | DSGN | Schmid John P. Director | 26,965 | $3.6988 | $99,738 | 57,639 (Indirect Direct) | View |
| 2024-03-14 Purchase | 2024-03-14 9:03 pm | Xeris Biopharma Holdings Inc. | XERS | Schmid John P. Director | 4,500 | $2.16 | $9,720 | 74,159 (Indirect Direct) | View |
| 2023-11-16 Purchase | 2023-11-17 6:35 pm | Xeris Biopharma Holdings Inc. | XERS | Schmid John P. Director | 6,500 | $1.51 | $9,815 | 69,659 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2024-02-09 06:13 am | N/A N/A | Helix Acquisition Corp. II | HLXB | Schmid John P. Director | 0 | $0 | 30,000 (Direct) | View |
| 2024-01-03 Option Award | 2024-01-05 4:58 pm | N/A 2034-01-02 | ANAPTYSBIO INC | ANAB | Schmid John P. Director | 22,540 | $0 | 22,540 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-16 4:09 pm | N/A 2033-06-14 | Poseida Therapeutics Inc. | PSTX | Schmid John P. Director | 47,000 | $0 | 66,650 (Direct) | View |
| 2023-06-07 Option Award | 2023-06-07 4:55 pm | N/A N/A | Xeris Biopharma Holdings Inc. | XERS | Schmid John P. Director | 42,500 | $0 | 63,159 (Direct) | View |
| 2023-05-31 Option Award | 2023-06-02 4:31 pm | N/A 2033-05-30 | Design Therapeutics Inc. | DSGN | Schmid John P. Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2023-01-06 Option Award | 2023-01-10 7:11 pm | N/A 2033-01-05 | ANAPTYSBIO INC | ANAB | Schmid John P. Director | 14,500 | $0 | 14,500 (Direct) | View |
| 2022-06-16 Option Award | 2022-06-16 8:56 pm | N/A 2032-06-15 | Poseida Therapeutics Inc. | PSTX | Schmid John P. Director | 48,150 | $0 | 48,150 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-16 5:10 pm | N/A 2032-06-14 | Design Therapeutics Inc. | DSGN | Schmid John P. Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2022-06-08 Option Award | 2022-06-09 5:13 pm | 2022-06-08 2032-06-08 | Xeris Biopharma Holdings Inc. | XERS | Schmid John P. Director | 40,000 | $0 | 45,659 (Direct) | View |
| 2022-02-10 Option Award | 2022-02-14 4:50 pm | N/A 2032-02-09 | ANAPTYSBIO INC | ANAB | Schmid John P. Director | 9,200 | $0 | 9,200 (Direct) | View |
| 2021-10-05 Option Award | 2021-10-05 7:41 pm | N/A 2028-05-15 | Xeris Biopharma Holdings Inc. | XERS | Schmid John P. Director | 73,335 | $0 | 73,335 (Direct) | View |
| 2021-10-05 Disposition | 2021-10-05 5:37 pm | N/A 2028-05-15 | XERIS PHARMACEUTICALS INC | XERS | Schmid John P. Director | 73,335 | $0 | 0 (Direct) | View |
| 2021-07-23 Option Award | 2021-07-26 8:32 pm | N/A 2031-07-23 | Poseida Therapeutics Inc. | PSTX | Schmid John P. Director | 25,833 | $0 | 25,833 (Direct) | View |
| 2021-06-16 Option Award | 2021-06-17 5:03 pm | N/A 2031-06-15 | Poseida Therapeutics Inc. | PSTX | Schmid John P. Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2021-06-08 Option Award | 2021-06-08 7:08 pm | N/A 2031-06-08 | XERIS PHARMACEUTICALS INC | XERS | Schmid John P. Director | 11,228 | $0 | 11,228 (Direct) | View |
| 2021-03-25 Option Award | 2021-03-29 5:55 pm | N/A 2031-03-24 | Design Therapeutics Inc. | DSGN | Schmid John P. Director | 15,000 | $0 | 15,000 (Direct) | View |
Ownership | 2021-03-25 9:08 pm | N/A N/A | Design Therapeutics Inc. | DSGN | Schmid John P. Director | 0 | $0 | 30,674 (Direct) | View |
| 2021-03-19 Disposition | 2021-03-19 5:33 pm | N/A N/A | Neos Therapeutics Inc. | NEOS | Schmid John P. Director | 138,715 | $0 | 0 (Direct) | View |
| 2021-02-10 Option Award | 2021-02-12 9:36 pm | N/A 2031-02-09 | ANAPTYSBIO INC | ANAB | Schmid John P. Director | 11,000 | $0 | 11,000 (Direct) | View |
Ownership | 2020-10-19 9:08 pm | N/A N/A | Helix Acquisition Corp | HLXA | Schmid John P. Director | 0 | $0 | 30,000 (Direct) | View |
| 2020-07-09 Option Award | 2020-07-13 7:00 pm | N/A 2030-07-08 | Poseida Therapeutics Inc. | PSTX | Schmid John P. Director | 20,000 | $0 | 20,000 (Direct) | View |
Ownership | 2020-07-09 6:00 pm | N/A 2028-07-16 | Poseida Therapeutics Inc. | PSTX | Schmid John P. Director | 0 | $0 | 48,114 (Direct) | View |
| 2020-06-10 Option Award | 2020-06-11 8:24 pm | N/A N/A | Neos Therapeutics Inc. | NEOS | Schmid John P. Director | 23,453 | $0 | 23,453 (Direct) | View |
| 2020-06-04 Option Award | 2020-06-04 9:02 pm | N/A 2030-06-04 | XERIS PHARMACEUTICALS INC | XERS | Schmid John P. Director | 11,228 | $0 | 11,228 (Direct) | View |
| 2020-02-12 Option Award | 2020-02-13 5:08 pm | N/A 2030-02-11 | ANAPTYSBIO INC | ANAB | Schmid John P. Director | 11,000 | $0 | 11,000 (Direct) | View |
| 2019-06-13 Option Award | 2019-06-17 5:34 pm | N/A 2029-06-13 | Neos Therapeutics Inc. | NEOS | Schmid John P. Director | 46,907 | $0 | 46,907 (Direct) | View |